https://www.indianpharmapost.com/gileads-trodelvy-falls-short-on-progression-free-survival-in-key-breast-cancer-trial-181902025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/glenmark-secures-china-approval-for-ryaltris-182012025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/novo-nordisk-india-partners-with-emcure-to-commercialise-poviztra-in-india-182002025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/biohaven-disappointed-as-rare-disease-therapy-faces-fda-setback-despite-promising-results-181992025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/venus-remedies-expands-asean-presence-with-new-drug-approvals-in-vietnam-181982025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/relmada-gains-fda-backing-for-two-registrational-trials-and-reports-92-response-with-ndv-01-in-bladder-cancer-181972025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/bristol-myers-squibb-prices-5-billion-senior-unsecured-notes-offering-181962025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/touchlight-unveils-next-gen-circular-dna-portfolio-for-advanced-gene-therapies-181952025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-lifesciences-posts-q2-fy26-pat-at-rs-12586-cr-181942025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/johnson-johnson-gets-fda-nod-for-new-depression-treatment-181932025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/soukya-launches-rs-125-crore-100-bed-ayush-hospital-in-bengaluru-181922025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazeneca-delivers-double-digit-growth-181912025-11-10T00:00:00+05:30always0.9https://www.indianpharmapost.com/marksans-pharmas-goa-unit-clears-fda-inspection-182022025-11-10T00:00:00+05:30always0.9